Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: UK101, UK 101

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $239 | In Stock | In Stock | |
| 5 mg | $446 | In Stock | In Stock | |
| 10 mg | $718 | In Stock | In Stock | |
| 25 mg | $1,450 | In Stock | In Stock |
| Description | UK-101 is a small molecule inhibitor and a selective inhibitor of the immunoproteasome β1i (LMP2) subunit (IC50=104 nM), with 144-fold and 10-fold selectivity over the β1c and β5 subunits, respectively. This compound can induce apoptosis, possesses antitumor activity, and can be used for prostate cancer-related research. |
| Targets & IC50 | Immunoproteasome β1c:15 μM, LMP2:104 nM, Immunoproteasome β5:1 μM |
| In vitro | Methods: PC-3 cells were treated with various concentrations of UK-101 (1-8 μM) for 24 hours, and cell cycle distribution, p27 protein accumulation, and PARP cleavage were detected. Results: UK-101 induced cell cycle arrest at the G1 phase, increased the number of cells in the G1 phase, enhanced p27 protein accumulation, and significantly increased PARP cleavage in a dose-dependent manner.[1] |
| In vivo | Methods: To detect the in vivo antitumor activity and toxicity of UK-101, tumor-bearing mice were intraperitoneally injected with UK-101 (1-3 mg/kg, twice weekly for 3 weeks), tumor volume changes were measured, and mouse body weight was monitored. Results: UK-101 treatment reduced tumor volume in a dose-dependent manner, with significant tumor volume reduction at the 3 mg/kg dose; meanwhile, mouse body weight remained stable during the treatment period, indicating low systemic toxicity.[1] |
| Synonyms | UK101, UK 101 |
| Molecular Weight | 484.74 |
| Formula | C25H48N2O5Si |
| Cas No. | 1000313-40-5 |
| Smiles | C([C@@H](NC([C@@H](NC(CCCCCC)=O)C)=O)CC(C)C)(=O)[C@@]1(CO[Si](C(C)(C)C)(C)C)CO1 |
| Relative Density. | 1.009 g/cm3 (Predicted) |
| Storage | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 237.5 mg/mL (489.95 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 3.3 mg/mL (6.81 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.